PMID: 7940134May 1, 1994Paper

The direct vascular relaxing action of betaxolol, carteolol and timolol in porcine long posterior ciliary artery

Survey of Ophthalmology
R K HesterL DeSantis

Abstract

The vascular relaxing properties of three beta adrenoceptor antagonists, betaxolol, carteolol and timolol, currently used in the treatment of glaucoma, were characterized, compared and contrasted in the porcine long posterior ciliary artery. Isolated arterial ring segments precontracted with increased extracellular KCl (plus 40 mM) or the thromboxane analog, U-46619 (3 x 10(-7) M), were relaxed in a concentration-dependent fashion by betaxolol, carteolol, timolol or nitroprusside. In vessel segments depolarized with increased extracellular KCl, EC50 values indicated that the intrinsic relaxant sensitivity to betaxolol was equal to that of nitroprusside, six-fold greater than that of carteolol, and ten-fold greater than that of timolol. Similarly, the maximum relaxation occurring at equimolar concentrations (10(-4) M) for the beta adrenoceptor antagonists was betaxolol > carteolol = timolol. Qualitatively similar results were noted in ring segments of the rabbit external iliac artery precontracted with increased extracellular KCl (plus 30 mM). Under conditions in which specific receptor-linked events are absent and voltage-gated Ca++ entry is maximized, the Ca++ concentration response relationship in porcine long posterior cilia...Continue Reading

References

Jan 1, 1977·Annual Review of Pharmacology and Toxicology·A Fleckenstein
Dec 15, 1991·American Journal of Ophthalmology·C MessmerD Stümpfig
Jan 1, 1988·Journal of Ocular Pharmacology·L Pillunat, R Stodtmeister
Jun 1, 1983·Japanese Journal of Pharmacology·M Sakanashi, S Takeo

❮ Previous
Next ❯

Citations

Oct 17, 2006·Wiener medizinische Wochenschrift·Hemma Resch, Gerhard Garhofer
Sep 24, 1999·European Journal of Pharmacology·J MelenaN N Osborne
Jul 23, 1999·Survey of Ophthalmology·N N OsborneM S Nash
Feb 15, 2001·Progress in Retinal and Eye Research·I O HaefligerT F Lüscher
Feb 27, 2003·Progress in Retinal and Eye Research·Dao-Yi YuPaula K Yu
Oct 25, 2003·Progress in Retinal and Eye Research·Vital P CostaLuis Metzner Serra
Jan 5, 2002·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·R D SteigerwaltR Minicucci
Jul 9, 2002·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Jong Hyun KimWon Chan Park
Jun 28, 2003·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Show-Jen HongJim C Fong
Jul 29, 2004·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Kwou-Yeung WuShow-Jen Hong
Oct 19, 2007·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Junji Narioka, Yuichi Ohashi
Jul 1, 1997·The British Journal of Ophthalmology·C H BuckleyC J O'Brien
Dec 3, 2013·European Journal of Pharmacology·Chihiro Mayama
Oct 1, 1995·American Journal of Ophthalmology·S OrgülG A Cioffi
Oct 12, 2010·Progress in Retinal and Eye Research·Makoto Araie, Chihiro Mayama
Jul 5, 2005·Expert Opinion on Investigational Drugs·R David
Nov 30, 2002·Experimental Eye Research·Eun Woo CheonWan Sung Choi
Aug 14, 1998·Experimental Eye Research·D Y YuL Desantis
Aug 27, 1999·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Y TamakiM Nagahara
May 1, 1997·Clinical Pharmacology and Therapeutics·L SchmettererM Wolzt
Sep 11, 1998·Journal of Cardiovascular Pharmacology·A M Hoste, S U Sys
Oct 28, 1999·Current Opinion in Ophthalmology·N N OsborneJ P Wood
Oct 23, 2002·Acta Ophthalmologica Scandinavica·Elina Vainio-JylhäKari Nummelin
Jan 1, 1997·Acta Ophthalmologica Scandinavica. Supplement·R A Hitchings
Nov 7, 2002·Japanese Journal of Pharmacology·Satoko EndoMakoto Tamai

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.